Product Information
DIVALPROEX SOD DR 125 MG TAB is a generic product labeled by Bionpharma Inc., priced at $0.0549 per EA under NDC 69452043330. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Nov 25, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/1
Manufacturer
Bionpharma Inc.NDC
69452043330
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078853FDA Approved
11/25/2008
TE Code
AB
On Market Since
6/26/2024
Pharmacological Classes
Price Statistics
The NADAC for DIVALPROEX SOD DR 125 MG TAB has been published 96 times since Dec 4, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0549 per EA |
|---|---|
| All-time high | $0.0607 (Apr 16, 2025) |
| All-time low | $0.0541 (Jun 17, 2026) |
| 52-week high | $0.0570 |
| 52-week low | $0.0541 |
| Median price | $0.0555 |
| Average price | $0.0563 |
| Largest weekly change | +6.1% (Dec 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
divalproex sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIVALPROEX SOD DR 125 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DIVALPROEX SOD DR 125 MG TAB, manufactured by Bionpharma Inc., is $0.0549 per EA (NDC 69452043330), effective Sep 30, 2026.
How has the price of DIVALPROEX SOD DR 125 MG TAB changed over time?
Over the history we have for it, the NADAC for DIVALPROEX SOD DR 125 MG TAB has held within roughly two percent of its current level. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for DIVALPROEX SOD DR 125 MG TAB?
Since Dec 4, 2024, the NADAC for DIVALPROEX SOD DR 125 MG TAB has ranged from a low of $0.0541 (Jun 17, 2026) to a high of $0.0607 (Apr 16, 2025), with a median of $0.0555 per EA.
Are there cheaper alternatives to DIVALPROEX SOD DR 125 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIVALPROEX SOD DR 125 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DIVALPROEX SOD DR 125 MG TAB?
DIVALPROEX SOD DR 125 MG TAB (NDC 69452043330) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.